STRG_F investigates who is making money from the peptide boom
The German investigative YouTube team looks at the business behind peptides and who profits from their rising popularity.
Recap by typeshit. Full story at STRG_F.
The German investigative YouTube team looks at the business behind peptides and who profits from their rising popularity.
Recap by typeshit. Full story at STRG_F.
The actor says GLP-1 drugs can make sense with a doctor's advice, but in his view no drug can stand in for working out.
Keltie Knight shares a personal take on body image pressure on women, tagged with GLP-1 and BookTok. It's a short social clip with few specifics.
Consumer Reports scored frozen meals on nutrition and taste as brands push high protein and GLP-1 friendly claims on the box.
8:41
The weekly tirzepatide update marks a milestone for the channel, with the scale finally dipping below 220 pounds.
The 1,200-person trial starts next year with MIT and Pitt researchers, funded by a $13 million Arnold Ventures grant, and will also track housing and jobs.
Prompted by Mayim Bialik's reaction to one dose, the doctors say evidence is promising for IBD but limited overall, and GLP-1s shouldn't replace autoimmune care.
Loading…